Self-service Version Enables Sponsors and CROs to Take Control of eConsent Technology
Plymouth Meeting, PA – 20 August 2018: CRF Health, the leading global provider of patient-centered eSource technology and service solutions for the life sciences industry, launches a self-service capability and a customer enablement program to empower CROs and Sponsors to manage all aspects of electronic informed consent using a licensed, cloud-based version of the industry’s first electronic informed consent platform with fully embedded design tool.
With TrialConsent®, pharmaceutical companies, CROs and sponsors can leverage their own in-house expertise to develop and implement informed consent documentation and enjoy the advantages of electronic implementation. Self-service licensed users have full access to TrialConsent Designer, an intuitive and visual design environment to develop and collaborate on informed consent documentation and forms. This web-based design environment provides the capability to rapidly develop documentation, embed multimedia, manage versions for different countries and sites, seamlessly implement translations, and manage the review and approval process of the patient-facing materials. Self-service users of TrialConsent Manager also have the capability to fully monitor study performance and metadata, and to manage the access rights of all study participants. CRF Health’s unique enablement program, tailored separately for Sponsors and CROs, ensures effective onboarding of the solution by providing a comprehensive training and mentoring program and ongoing support to ensure the solution is used effectively. Combined with optional services such as device procurement and logistics, this provides Sponsors and CROs with all they need to independently implement electronic informed consent using their own in-house expertise.
Rachael Wyllie, CEO commented: “CRF Health is committed to simplifying the path to approval, streamlining complex processes and delivering reliable results for superior clinical trial outcomes. The forward-thinking architecture behind our TrialConsent solution signifies a step-change in the way informed consent is handled by enhancing patient understanding, reducing trial costs and length, minimizing regulatory risk, and helping our partners make smarter decisions. Enabling our customers to implement electronic informed consent using their own resources and experts is part of our customer-focused product development activity, giving our customers the power to take control of their eConsent technology safely without utilizing a third party.”
For more information on CRF Health's TrialConsent® solution, please visit www.crfhealth.com.
About CRF Health
CRF Health is the leading global provider of patient-centered eSource technology solutions for the life sciences industry. With experience in more than 800 clinical trials, over 100 languages and across 74 countries, the company delivers best in class, fully integrated eSource solutions for pharma partners. Solutions include TrialMax®, an eCOA suite which consistently demonstrates the industry’s highest data accuracy, patient and site compliance, and patient retention, and TrialConsent®, the patient-centered, intuitive and interactive informed eConsent suite.
About the Author
Associate Director of Marketing at CRF HealthMore Content by Heather Bilinski